Markets:

Overview

News

Currencies

International

Treasuries

Vaxart, Inc. - Common Stock (NQ:VXRT)

0.3200 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vaxart, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Top movers in Monday's session ↗

February 24, 2025

Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

These stocks are moving in today's session ↗

February 24, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

February 24, 2025

The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Earnings Scheduled For November 13, 2024 ↗

November 13, 2024

Via Benzinga

Earnings Preview For Vaxart ↗

November 12, 2024

Via Benzinga

Recap: Vaxart Q4 Earnings ↗

March 14, 2024

Via Benzinga

Vaxart's Earnings: A Preview ↗

March 13, 2024

Via Benzinga

What's Going On With Vaxart Stock Today? ↗

January 17, 2024

Vaxart shares are trading higher by around 8% Wednesday afternoon. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services.

Via Benzinga

Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside ↗

August 15, 2024

Oppenheimer initiates Vaxart coverage with an Outperform rating and $4 price target, citing a bullish outlook on its oral vaccines for COVID-19 and norovirus.

Via Benzinga

VXRT Stock Earnings: Vaxart Misses EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

VXRT stock results show that Vaxart missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying ↗

June 21, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 18, 2024

Via Benzinga

Vaxart Stock Is Moving Higher After The Bell: What's Going On? ↗

June 17, 2024

Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds from a recent offering combined with reimbursements under its Project...

Via Benzinga

Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering ↗

June 14, 2024

Vaxart (VXRT) shares surged 23% in premarket session after receiving a $453 million project award from BARDA to conduct a COVID-19 vaccine study.

Via Benzinga

Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

June 14, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 14, 2024

Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 13, 2024

Via Benzinga

Palo Alto Networks Shares Drop After Q3 Results, In-Line Guidance: The Details ↗

May 20, 2024

Palo Alto Networks reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.25 by 5.6%. Quarterly sales clocked in at $1.985 billion which beat the analyst...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 14, 2024

Via Benzinga

VXRT Stock Earnings: Vaxart Meets EPS, Beats Revenue for Q1 2024 ↗

May 13, 2024

VXRT stock results show that Vaxart met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 13, 2024

Via Benzinga

Vaxart Stock Climbs After Blockbuster Q1 Revenue ↗

May 13, 2024

Vaxart reported quarterly losses of 14 cents per share, inline with the analyst consensus estimate. Quarterly sales clocked in at $2.181 million, beating the analyst consensus estimate of $800,000 by...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 10, 2024

Via Benzinga

Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024? ↗

April 09, 2024

These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around.

Via InvestorPlace

VXRT Stock Earnings: Vaxart Beats EPS, Beats Revenue for Q4 2023 ↗

March 14, 2024

VXRT stock results show that Vaxart beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 31, 2024

Via Benzinga

Earnings Scheduled For March 14, 2024 ↗

March 14, 2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Via Benzinga

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 31, 2024

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 16, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.